Far East Bio-Tec. Co., Ltd. Statistics
Far East Bio-Tec. Co., Ltd. (6886) Stock Statistics & Valuation Metrics
Total Valuation
Far East Bio-Tec. Co., Ltd. has a market cap or net worth of TWD 1.35B. The enterprise value is ―.
- Market Cap
- TWD 1.35B
- Enterprise Value
- ―
Share Statistics
Far East Bio-Tec. Co., Ltd. has 34,991,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 34,991,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Far East Bio-Tec. Co., Ltd.’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 8.43%.
- Return on Equity (ROE)
- 0.10
- Return on Assets (ROA)
- 0.09
- Return on Invested Capital (ROIC)
- 8.43%
- Return on Capital Employed (ROCE)
- 0.11
- Revenue Per Employee
- 3.33M
- Profits Per Employee
- 495.73K
- Employee Count
- 121
- Asset Turnover
- 0.57
- Inventory Turnover
- 1.82
Valuation Ratios
The current PE Ratio of Far East Bio-Tec. Co., Ltd. is 20.13. Far East Bio-Tec. Co., Ltd.’s PEG ratio is 0.20.
- PE Ratio
- 20.13
- PS Ratio
- 3.10
- PB Ratio
- 2.05
- Price to FCF
- 46.26
- Price to Operating Cash Flow
- 26.51
- PEG Ratio
- 0.20
Income Statement
In the last 12 months, Far East Bio-Tec. Co., Ltd. had revenue of 402.70M and earned 59.98M in profits. Earnings per share was 1.89.
- Revenue
- 402.70M
- Gross Profit
- 202.84M
- Operating Income
- 68.60M
- Pretax Income
- 75.69M
- Net Income
- 59.98M
- EBITDA
- 98.86M
- Earnings Per Share (EPS)
- 1.89
Cash Flow
In the last 12 months, operating cash flow was 46.59M and capital expenditures -17.35M, giving a free cash flow of 29.23M billion.
- Operating Cash Flow
- 46.59M
- Free Cash Flow
- 29.23M
- Free Cash Flow per Share
- 0.91
Dividends & Yields
Far East Bio-Tec. Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 1.29%
- Dividend Per Share
- ―
- Dividend Yield
- 1.29%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 2.16%
- Earnings Yield
- 5.06%
Stock Price Statistics
- Beta
- 0.25
- 52-Week Price Change
- -10.40%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 37.02
- Average Volume (3m)
- 1,871
Financial Position
Far East Bio-Tec. Co., Ltd. as a current ratio of 5.88, with Debt / Equity ratio of 9.66%
- Current Ratio
- 5.88
- Quick Ratio
- 4.36
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- -2.17
- Interest Coverage Ratio
- 61.74
Taxes
In the past 12 months, Far East Bio-Tec. Co., Ltd. has paid 15.71M in taxes.
- Income Tax
- 15.71M
- Effective Tax Rate
- 0.21
Enterprise Valuation
Far East Bio-Tec. Co., Ltd. EV to EBITDA ratio is 12.95, with an EV/FCF ratio of 39.09.
- EV to Sales
- 2.62
- EV to EBITDA
- 12.95
- EV to Free Cash Flow
- 39.09
- EV to Operating Cash Flow
- 24.53
Balance Sheet
Far East Bio-Tec. Co., Ltd. has TWD 276.41M in cash and marketable securities with TWD 57.25M in debt, giving a net cash position of TWD 219.17M billion.
- Cash & Marketable Securities
- TWD 276.41M
- Total Debt
- TWD 57.25M
- Net Cash
- TWD 219.17M
- Net Cash Per Share
- TWD 6.26
- Tangible Book Value Per Share
- TWD 18.87
Margins
Gross margin is 44.82%, with operating margin of 15.03%, and net profit margin of 14.32%.
- Gross Margin
- 44.82%
- Operating Margin
- 15.03%
- Pretax Margin
- 18.06%
- Net Profit Margin
- 14.32%
- EBITDA Margin
- 20.23%
- EBIT Margin
- 15.03%
Analyst Forecast
The average price target for Far East Bio-Tec. Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 6.94%
- EPS Growth Forecast
- 6.32%
